摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-溴-2-氯-4-甲基嘧啶 | 633328-95-7

中文名称
5-溴-2-氯-4-甲基嘧啶
中文别名
2-氯-5-溴-4-甲基嘧啶;2-氯-4-甲基-5-溴嘧啶
英文名称
5-bromo-2-chloro-4-methylpyrimidine
英文别名
——
5-溴-2-氯-4-甲基嘧啶化学式
CAS
633328-95-7
化学式
C5H4BrClN2
mdl
——
分子量
207.457
InChiKey
IIALSLVGUGOODS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    281.5±20.0 °C(Predicted)
  • 密度:
    1.724±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933599090
  • 危险性防范说明:
    P261,P264,P271,P280,P302+P352,P304+P340+P312,P305+P351+P338,P332+P313,P337+P313,P403+P233,P405,P501
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温

SDS

SDS:4503bcb53278b4064ec81fcbb66dd640
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Bromo-2-chloro-4-methylpyrimidine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-chloro-4-methylpyrimidine
CAS number: 633328-95-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H4BrClN2
Molecular weight: 207.5

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

5-溴-2-氯-4-甲基嘧啶是一种高度功能化的嘧啶类化合物,主要用于有机合成试剂,在基础有机化学研究中发挥着重要作用。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-溴-2-氯-4-甲基嘧啶tris-(dibenzylideneacetone)dipalladium(0) 、 dichloro[1,1'-bis(di-t-butylphosphino)ferrocene]palladium(II) 、 caesium carbonate三乙胺4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下, 以 1,4-二氧六环乙醇 为溶剂, 反应 17.0h, 生成 3-(4-methyl-5-vinylpyrimidin-2-yl)-3-azabicyclo[3.1.0]hexan-2-one
    参考文献:
    名称:
    [EN] PLASMA KALLIKREIN INHIBITORS
    [FR] INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE
    摘要:
    本发明提供了一种式(I)的化合物,以及包括一种或多种所述化合物的药物组合物,并且使用所述化合物治疗或预防可能受益于抑制血浆激肽酶的一种或多种疾病状态的方法,包括遗传性血管性水肿、葡萄膜炎、后部葡萄膜炎、湿性老年性黄斑水肿、糖尿病性黄斑水肿、糖尿病视网膜病变和视网膜静脉阻塞。这些化合物是血浆激肽酶的选择性抑制剂。
    公开号:
    WO2021257353A1
  • 作为产物:
    描述:
    2-氨基-4-甲基-5-溴嘧啶亚硝酸特丁酯苄基三乙基氯化铵 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以45%的产率得到5-溴-2-氯-4-甲基嘧啶
    参考文献:
    名称:
    ISOQUINOLINES AS INHIBITORS OF HPK1
    摘要:
    描述了异喹啉化合物及其作为HPK1(造血激酶1)抑制剂的用途。这些化合物在治疗依赖于HPK1的疾病和增强免疫应答方面非常有用。还描述了抑制HPK1的方法、治疗依赖于HPK1的疾病的方法、增强免疫应答的方法,以及制备异喹啉化合物的方法。
    公开号:
    US20180282282A1
点击查看最新优质反应信息

文献信息

  • [EN] AMINOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS<br/>[FR] DÉRIVÉS D'AMINOPYRIDINE UTILISÉS EN TANT QU'INHIBITEURS DE LA PHOSPHATIDYLINOSITOL PHOSPHATE KINASE
    申请人:PETRA PHARMA CORP
    公开号:WO2019126731A1
    公开(公告)日:2019-06-27
    The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula: (I) where A, B, R1, X1, X2, and W are described herein.
    这项发明涉及PI5P4K抑制剂,用于治疗癌症、神经退行性疾病、炎症性疾病和代谢性疾病,其化学式为:(I),其中A、B、R1、X1、X2和W如本文所述。
  • TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
    申请人:CHAN Ho Man
    公开号:US20160176882A1
    公开(公告)日:2016-06-23
    A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R 1 , R 2 , R 3 , R 4 , R 5 , and n are as defined herein.
    提供了一种由化合物(I)或其药学上可接受的盐组成的药物,已被证明对治疗PRC2介导的疾病或紊乱有用:其中R1、R2、R3、R4、R5和n的定义如本文所述。
  • [EN] IMIDAZOPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER<br/>[FR] COMPOSÉS D'IMIDAZOPYRIMIDINE UTILES POUR LE TRAITEMENT DU CANCER
    申请人:NOVARTIS AG
    公开号:WO2017221100A1
    公开(公告)日:2017-12-28
    A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R3, R4, R6, and R7 are as defined herein.
    提供了一种具有以下结构式(IA)的化合物,或其药用盐,已被证明对治疗PRC2介导的疾病或紊乱有用:其中A,R3,R4,R6和R7如本文所定义。
  • [EN] 3-BENZOYL-1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS MKK4 INHIBITORS FOR TREATING LIVER DISEASES<br/>[FR] DÉRIVÉS DE 3-BENZOYL-1H-PYRROLO[2,3-B]PYRIDINE UTILISÉS EN TANT QU'INHIBITEURS DE MKK4 POUR LE TRAITEMENT DE MALADIES DU FOIE
    申请人:HEPAREGENIX GMBH
    公开号:WO2021144287A1
    公开(公告)日:2021-07-22
    The invention relates to compounds of formula (I) which are inhibitors of MKK4 (mitogen-activated protein kinase kinase 4) and their use in promoting liver regeneration or reducing or preventing hepatocyte death. The compounds selectively inhibit protein kinase MKK4 over protein kinases JNK1 and MKK7. In formula (I), especially, Rw is -NR10SO2R12; either a) Rx and R y are F and R z and R zz are H; or b ) R x, R y and R zz are independently halogen and R z is H; R 5 is substituted phenyl or pyrimidinyl.
    该发明涉及式(I)的化合物,这些化合物是MKK4(丝裂原活化蛋白激酶激酶4)的抑制剂,用于促进肝再生或减少或预防肝细胞死亡。这些化合物选择性地抑制蛋白激酶MKK4而不是蛋白激酶JNK1和MKK7。在式(I)中,特别是,Rw为-NR10SO2R12;要么a)Rx和R y为F,R z和R zz为H;要么b)Rx,R y和R zz分别为卤素,R z为H;R 5为取代苯基或嘧啶基。
  • [EN] PESTICIDAL COMPOUNDS<br/>[FR] COMPOSÉS PESTICIDES
    申请人:BASF SE
    公开号:WO2018108671A1
    公开(公告)日:2018-06-21
    The present invention relates to the compounds of formula (I), and the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof wherein the variables are defined according to the description. The compounds of formula (I), as well as the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof, are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.
    本发明涉及式(I)的化合物,以及其N-氧化物、立体异构体、互变异构体和农业或兽医学上可接受的盐,其中变量根据说明书中的定义。式(I)的化合物,以及其N-氧化物、立体异构体、互变异构体和农业或兽医学上可接受的盐,对于对抗或控制无脊椎动物害虫,特别是节肢动物害虫和线虫害虫是有用的。该发明还涉及一种利用这些化合物控制无脊椎动物害虫的方法,以及包括所述化合物的植物繁殖材料和农业和兽医组合物。
查看更多